2022 Q1 Form 10-Q Financial Statement
#000156459022018574 Filed on May 06, 2022
Income Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| Revenue | $159.5M | $113.9M |
| YoY Change | 40.0% | 23.44% |
| Cost Of Revenue | $33.33M | $20.36M |
| YoY Change | 63.72% | 16.34% |
| Gross Profit | $126.2M | $93.58M |
| YoY Change | 34.84% | 24.94% |
| Gross Profit Margin | 79.1% | 82.13% |
| Selling, General & Admin | $137.1M | $71.89M |
| YoY Change | 90.66% | 13.04% |
| % of Gross Profit | 108.62% | 76.82% |
| Research & Development | $60.25M | $34.55M |
| YoY Change | 74.42% | 22.94% |
| % of Gross Profit | 47.75% | 36.92% |
| Depreciation & Amortization | $15.15M | $7.301M |
| YoY Change | 107.46% | 21.89% |
| % of Gross Profit | 12.0% | 7.8% |
| Operating Expenses | $197.3M | $106.4M |
| YoY Change | 85.39% | 15.44% |
| Operating Profit | -$71.14M | -$12.86M |
| YoY Change | 453.25% | -25.68% |
| Interest Expense | $491.0K | $562.0K |
| YoY Change | -12.63% | -240.5% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $543.0K | -$183.0K |
| YoY Change | -396.72% | -84.75% |
| Pretax Income | -$71.09M | -$13.60M |
| YoY Change | 422.57% | -28.41% |
| Income Tax | $300.0K | $100.0K |
| % Of Pretax Income | ||
| Net Earnings | -$71.42M | -$13.73M |
| YoY Change | 420.09% | -27.86% |
| Net Earnings / Revenue | -44.77% | -12.05% |
| Basic Earnings Per Share | -$0.53 | |
| Diluted Earnings Per Share | -$530.9K | -$106.9K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 134.5M shares | |
| Diluted Shares Outstanding | 134.5M shares |
Balance Sheet
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $586.9M | $413.8M |
| YoY Change | 41.84% | |
| Cash & Equivalents | $586.9M | $413.8M |
| Short-Term Investments | ||
| Other Short-Term Assets | $40.73M | $21.50M |
| YoY Change | 89.44% | |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $98.14M | $71.20M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $725.8M | $506.5M |
| YoY Change | 43.29% | |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $126.2M | $119.5M |
| YoY Change | 5.64% | |
| Goodwill | $540.0M | |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $24.09M | $13.80M |
| YoY Change | 74.54% | |
| Total Long-Term Assets | $946.5M | $328.8M |
| YoY Change | 187.86% | |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $725.8M | $506.5M |
| Total Long-Term Assets | $946.5M | $328.8M |
| Total Assets | $1.672B | $835.3M |
| YoY Change | 100.2% | |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $14.41M | $5.500M |
| YoY Change | 161.96% | |
| Accrued Expenses | $58.89M | $32.70M |
| YoY Change | 80.1% | |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $408.6M | $271.7M |
| YoY Change | 50.39% | |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $46.95M | $48.50M |
| YoY Change | -3.19% | |
| Other Long-Term Liabilities | $52.31M | $52.10M |
| YoY Change | 0.4% | |
| Total Long-Term Liabilities | $99.26M | $100.6M |
| YoY Change | -1.33% | |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $408.6M | $271.7M |
| Total Long-Term Liabilities | $99.26M | $100.6M |
| Total Liabilities | $507.9M | $372.2M |
| YoY Change | 36.45% | |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $1.164B | -$265.1M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $1.672B | $835.3M |
| YoY Change | 100.2% |
Cashflow Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$71.42M | -$13.73M |
| YoY Change | 420.09% | -27.86% |
| Depreciation, Depletion And Amortization | $15.15M | $7.301M |
| YoY Change | 107.46% | 21.89% |
| Cash From Operating Activities | $10.28M | $28.30M |
| YoY Change | -63.66% | 509.83% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $7.525M | $2.393M |
| YoY Change | 214.46% | -133.1% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$1.038M | $0.00 |
| YoY Change | -100.0% | |
| Cash From Investing Activities | -$16.20M | -$4.586M |
| YoY Change | 253.14% | -56.53% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 6.542M | 10.77M |
| YoY Change | -39.27% | -93.62% |
| NET CHANGE | ||
| Cash From Operating Activities | 10.28M | 28.30M |
| Cash From Investing Activities | -16.20M | -4.586M |
| Cash From Financing Activities | 6.542M | 10.77M |
| Net Change In Cash | 631.0K | 34.48M |
| YoY Change | -98.17% | -78.83% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $10.28M | $28.30M |
| Capital Expenditures | $7.525M | $2.393M |
| Free Cash Flow | $2.759M | $25.90M |
| YoY Change | -89.35% | 118.22% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2022Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2022Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
33332000 | |
| CY2021Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
20359000 | |
| CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
126184000 | |
| CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
93579000 | |
| CY2022Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
93915000 | |
| CY2021Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
53965000 | |
| CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
60254000 | |
| CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
34545000 | |
| CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
43152000 | |
| CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
17927000 | |
| CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
197321000 | |
| CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
106437000 | |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1164385000 | |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-71419000 | |
| CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-13732000 | |
| CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
37209000 | |
| CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
10303000 | |
| CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
15147000 | |
| CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7301000 | |
| CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-71137000 | |
| CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12858000 | |
| CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
491000 | |
| CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
562000 | |
| CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
543000 | |
| CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-183000 | |
| CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-71085000 | |
| CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-13603000 | |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
334000 | |
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
129000 | |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-71419000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13732000 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.53 | |
| CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.44 | |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
134530010 | |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
31357060 | |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-71419000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13732000 | |
| CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
345000 | |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-24000 | |
| CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-71074000 | |
| CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-13756000 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-272102000 | |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
11038000 | |
| CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
9710000 | |
| CY2021Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-24000 | |
| CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-13732000 | |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-265110000 | |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1189289000 | |
| CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
6795000 | |
| CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
39375000 | |
| CY2022Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
345000 | |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-71419000 | |
| CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-554000 | |
| CY2022Q1 | pcor |
Noncash Lease Expense
NoncashLeaseExpense
|
-2156000 | |
| CY2021Q1 | pcor |
Noncash Lease Expense
NoncashLeaseExpense
|
-1866000 | |
| CY2022Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
477000 | |
| CY2021Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-605000 | |
| CY2022Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-352000 | |
| CY2021Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-27000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-34125000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-20723000 | |
| CY2022Q1 | pcor |
Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
|
4066000 | |
| CY2021Q1 | pcor |
Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
|
1562000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4925000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4601000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
339000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
590018000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
417107000 | |
| CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
38000 | |
| CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
40000 | |
| CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
98000 | |
| CY2022Q1 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
405000 | |
| CY2021Q1 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
93000 | |
| CY2022Q1 | pcor |
Operating Cash Flows From Finance Leases
OperatingCashFlowsFromFinanceLeases
|
511000 | |
| CY2021Q1 | pcor |
Operating Cash Flows From Finance Leases
OperatingCashFlowsFromFinanceLeases
|
525000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-3516000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-4357000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
5115000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
8774000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
6639000 | |
| CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1870000 | |
| CY2021Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1372000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
10284000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
28296000 | |
| CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7525000 | |
| CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2393000 | |
| CY2022Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
7632000 | |
| CY2021Q1 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
2193000 | |
| CY2022Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
2329000 | |
| CY2022Q1 | pcor |
Settlement Of Post Close Working Capital Adjustments From Business Combinations
SettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinations
|
1291000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-16195000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4586000 | |
| CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
6907000 | |
| CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
11627000 | |
| CY2021Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
540000 | |
| CY2022Q1 | pcor |
Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
|
365000 | |
| CY2021Q1 | pcor |
Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
|
314000 | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6542000 | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10773000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
631000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
34483000 | |
| CY2022Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
175000 | |
| CY2021Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-629000 | |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
589212000 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
383253000 | |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
590018000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
417107000 | |
| CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
586914000 | |
| CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
413761000 | |
| CY2021Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
242000 | |
| CY2022Q1 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
3104000 | |
| CY2021Q1 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
3104000 | |
| CY2022Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
2518000 | |
| CY2021Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1732000 | |
| CY2022Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
454000 | |
| CY2021Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
407000 | |
| CY2022Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1521000 | |
| CY2021Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
399000 | |
| CY2022Q1 | pcor |
Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
|
1829000 | |
| CY2021Q1 | pcor |
Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
|
591000 | |
| CY2022Q1 | pcor |
Net Change In Deferred Offering Costs Accrued But Not Paid
NetChangeInDeferredOfferingCostsAccruedButNotPaid
|
270000 | |
| CY2021Q1 | pcor |
Net Change In Deferred Offering Costs Accrued But Not Paid
NetChangeInDeferredOfferingCostsAccruedButNotPaid
|
2113000 | |
| CY2022Q1 | pcor |
Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
|
2166000 | |
| CY2021Q1 | pcor |
Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
|
83000 | |
| CY2022Q1 | pcor |
Conversion Of Available For Sale Debt Securities Into Equity Securities
ConversionOfAvailableForSaleDebtSecuritiesIntoEquitySecurities
|
3292000 | |
| CY2022Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
6993000 | |
| CY2021Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
76000 | |
| CY2022Q1 | pcor |
Noncash Net Change Due To Operating Lease Remeasurements
NoncashNetChangeDueToOperatingLeaseRemeasurements
|
-1676000 | |
| CY2021Q1 | pcor |
Noncash Net Change Due To Operating Lease Remeasurements
NoncashNetChangeDueToOperatingLeaseRemeasurements
|
-14000 | |
| CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.34%;text-indent:0%;;color:#231F20;font-size:10pt;font-weight:bold;font-style:italic;font-family:Arial;text-transform:none;font-variant: normal;">Use<span style="letter-spacing:-0.05pt;"> </span>of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.34%;color:#231F20;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>preparation<span style="letter-spacing:-0.05pt;"> </span>of condensed<span style="letter-spacing:-0.05pt;"> </span>consolidated<span style="letter-spacing:-0.1pt;"> </span>financial<span style="letter-spacing:-0.1pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>in<span style="letter-spacing:-0.05pt;"> </span>conformity<span style="letter-spacing:0.05pt;"> </span>with<span style="letter-spacing:-0.05pt;"> </span>U.S. GAAP requires management to make estimates and<span style="letter-spacing:-0.05pt;"> </span>assumptions<span style="letter-spacing:-0.05pt;"> </span>that affect<span style="letter-spacing:0.05pt;"> </span>the reported amounts of assets and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>disclosure<span style="letter-spacing:-0.05pt;"> </span>of contingent<span style="letter-spacing:-0.05pt;"> </span>assets and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>at the date of the condensed<span style="letter-spacing:-0.05pt;"> </span>consolidated<span style="letter-spacing:-0.1pt;"> </span>financial<span style="letter-spacing:-0.1pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>the reported amounts of revenue<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>expenses during<span style="letter-spacing:-0.05pt;"> </span>the reporting period. Management periodically<span style="letter-spacing:-0.1pt;"> </span>evaluates<span style="letter-spacing:-0.05pt;"> </span>its estimates and<span style="letter-spacing:-0.05pt;"> </span>assumptions<span style="letter-spacing:-0.05pt;"> </span>for continued<span style="letter-spacing:-0.05pt;"> </span>reasonableness,<span style="letter-spacing:-0.05pt;"> </span>primarily with<span style="letter-spacing:-0.05pt;"> </span>respect to revenue<span style="letter-spacing:-0.05pt;"> </span>recognition,<span style="letter-spacing:-0.05pt;"> </span>the period<span style="letter-spacing:-0.05pt;"> </span>of benefit of contract<span style="letter-spacing:0.05pt;"> </span>cost assets, the fair value<span style="letter-spacing:-0.05pt;"> </span>of assets acquired<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>assumed in<span style="letter-spacing:-0.05pt;"> </span>a business combination,<span style="letter-spacing:-0.05pt;"> </span>stock-based compensation<span style="letter-spacing:-0.05pt;"> </span>expense, including<span style="letter-spacing:-0.05pt;"> </span>the fair value<span style="letter-spacing:-0.05pt;"> </span>of the Company’s<span style="letter-spacing:-0.05pt;"> </span>common stock prior to the effective date of the Company’s initial public offering (“IPO”)<span style="letter-spacing:0.05pt;">, </span>the recoverability<span style="letter-spacing:-0.05pt;"> </span>of goodwill<span style="letter-spacing:-0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>long-lived<span style="letter-spacing:-0.1pt;"> </span>assets, useful<span style="letter-spacing:-0.05pt;"> </span>lives<span style="letter-spacing:-0.05pt;"> </span>of long-lived<span style="letter-spacing:-0.1pt;"> </span>assets, capitalization<span style="letter-spacing:-0.1pt;"> </span>of software development<span style="letter-spacing:-0.05pt;"> </span>costs<span style="letter-spacing:-0.1pt;">,</span><span style="letter-spacing:-0.05pt;"> </span>income<span style="letter-spacing:-0.05pt;"> </span>taxes, including<span style="letter-spacing:-0.1pt;"> </span>related reserves and<span style="letter-spacing:-0.05pt;"> </span>allowances, and self-insurance reserve estimates. Appropriate<span style="letter-spacing:-0.05pt;"> </span>adjustments, if any, to the estimates used<span style="letter-spacing:-0.05pt;"> </span>are made prospectively<span style="letter-spacing:-0.05pt;"> </span>based<span style="letter-spacing:-0.05pt;"> </span>upon<span style="letter-spacing:-0.05pt;"> </span>such periodic<span style="letter-spacing:-0.05pt;"> </span>evaluation.<span style="letter-spacing:-0.05pt;"> </span>Management bases<span style="letter-spacing:-0.05pt;"> </span>its estimates on historical<span style="letter-spacing:-0.05pt;"> </span>experience<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>on various<span style="color:#000000;"> </span>other assumptions<span style="letter-spacing:-0.05pt;"> </span>that management believes<span style="letter-spacing:-0.1pt;"> </span>to be reasonable.<span style="letter-spacing:-0.05pt;"> </span>Actual<span style="letter-spacing:-0.05pt;"> </span>results could<span style="letter-spacing:-0.05pt;"> </span>differ from our estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.34%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In light of the currently unknown duration and severity of the COVID-19 pandemic, we face a greater degree of uncertainty than normal in making the judgments and estimates needed to apply our significant accounting policies. As of the date these condensed consolidated financial statements were issued, the impacts of the COVID-19 pandemic did not have a significant impact on our estimates or judgments. Judgments and assumptions may change, as new events occur and additional information is obtained, as well as other factors related to the COVID-19 pandemic and economic recovery that could result in a meaningful impact on our condensed consolidated financial statements in future reporting periods.</p> | |
| CY2021Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
6000000.0 | |
| CY2021Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
7500000 | |
| CY2022Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 | |
| CY2022Q1 | us-gaap |
Contractual Obligation
ContractualObligation
|
4900000 | |
| CY2022Q1 | pcor |
Impairment On Investments
ImpairmentOnInvestments
|
0 | |
| CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
3500000 | |
| CY2022Q1 | pcor |
Available For Debt Securities Changes In Impairment
AvailableForDebtSecuritiesChangesInImpairment
|
0 | |
| CY2022Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
128200000 | |
| CY2021Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
93900000 | |
| CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
626700000 | |
| CY2022Q1 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.71 | |
| CY2022Q1 | us-gaap |
Self Insurance Reserve
SelfInsuranceReserve
|
1100000 | |
| CY2022Q1 | pcor |
Operating Lease Right Of Use Assets Operating Lease Liabilities
OperatingLeaseRightOfUseAssetsOperatingLeaseLiabilities
|
7000000.0 | |
| CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
224309000 | |
| CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
31808000 | |
| CY2022Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
192501000 | |
| CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
224123000 | |
| CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
22146000 | |
| CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
201977000 | |
| CY2022Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9662000 | |
| CY2021Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1748000 | |
| CY2022Q1 | us-gaap |
Goodwill
Goodwill
|
540000000.0 | |
| CY2022Q1 | pcor |
Goodwill Decreased By Due To Settlement Of Post Close Working Capital Adjustments From Business Combinations And Effect Of Foreign Currency Translation
GoodwillDecreasedByDueToSettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinationsAndEffectOfForeignCurrencyTranslation
|
900000 | |
| CY2022Q1 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
| CY2022Q1 | pcor |
Accrued Commissions And Bonuses Current
AccruedCommissionsAndBonusesCurrent
|
16198000 | |
| CY2021Q4 | pcor |
Accrued Commissions And Bonuses Current
AccruedCommissionsAndBonusesCurrent
|
29676000 | |
| CY2022Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
32043000 | |
| CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
25997000 | |
| CY2022Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
10651000 | |
| CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
10234000 | |
| CY2022Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
58892000 | |
| CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
65907000 | |
| CY2022Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
100000000.0 | |
| CY2021Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
100000000.0 | |
| CY2022Q1 | us-gaap |
Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
|
2022-05-07 | |
| CY2022Q1 | pcor |
Line Of Credit Facility Termination Date
LineOfCreditFacilityTerminationDate
|
2022-04-29 | |
| CY2022Q1 | us-gaap |
Line Of Credit
LineOfCredit
|
0 | |
| CY2022Q1 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
6500000 | |
| CY2021Q4 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
6500000 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
7642690 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
12.98 | |
| CY2022Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
697998 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
9.73 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
79940 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
21.08 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6864752 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
13.22 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5715153 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
11.78 | |
| CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
8700000 | |
| CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P0Y10M24D | |
| CY2022Q1 | pcor |
Employee Stock Purchase Plan Number Of End Participation Period Description
EmployeeStockPurchasePlanNumberOfEndParticipationPeriodDescription
|
Participants may end their participation at any time prior to the last 15 days of a purchase period | |
| CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
37209000 | |
| CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
10303000 | |
| CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
2166000 | |
| CY2021Q1 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
83000 | |
| CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
|
39375000 | |
| CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
|
10386000 | |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
300000 | |
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
100000 | |
| CY2022Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14402567 | |
| CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
102560820 | |
| CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
159516000 | |
| CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
113938000 |
